Papillary eccrine carcinoma

Summary

Papillary eccrine carcinoma (MONDO:0003531) is a cancer. A subtype of papillary adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	papillary eccrine carcinoma
Mondo ID	MONDO:0003531
DOID	DOID:5591
NCIT	C27254
SNOMED CT	254709009
Is cancer (heuristic)	yes

Also known as: papillary apocrine fibroadenoma · papillary eccrine adenoma · papillary eccrine carcinoma · tubular apocrine adenoma

Disease family

This is a subtype of papillary adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › papillary adenocarcinoma › papillary eccrine carcinoma

Related subtypes (10): breast papillary carcinoma, papillary thymic adenocarcinoma, fallopian tube papillary adenocarcinoma, ovarian serous surface papillary adenocarcinoma, gallbladder papillary neoplasm with an associated invasive carcinoma, papillary cystadenocarcinoma, thyroid gland papillary carcinoma, papillary lung adenocarcinoma, gastric papillary adenocarcinoma, papillary renal cell carcinoma

Subtypes (1): digital papillary eccrine carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.